KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin‑1 expression
Authors:
Open Access
- 19 March 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (6) , 4907-4913
Abstract
Clear cell renal cell carcinoma (ccRCC) is one of the most common types of kidney cancer and is accompanied by a poor prognosis due to a high potential for metastasis and recurrence. The mechanism of ccRCC metastasis is not well known. N‑lysine methyltransferase KMT5A serves a crucial role in the progression of human cancer; however, the function of KMT5A in the development of ccRCCs has not yet been investigated, which has triggered an interest in investigating the potential association between KMT5A and ccRCC. The present study demonstrates for the first time that KMT5A is a driving factor in ccRCC metastasis. The KMT5A expression level was revealed to be significantly higher in ccRCC tissues compared with adjacent normal tissues. Patients with ccRCC whose tumors expressed high levels of KMT5A were demonstrated to have significantly shorter postoperative survival times. In vitro knockdown of KMT5A expression in 786‑O cells inhibited cell migration and invasion. KMT5A reduced cadherin‑1 (CDH1) protein levels by directly inhibiting its transcription. The CDH1 mRNA levels were inversely correlated with KMT5A expression in ccRCC samples. Patients with high tumor KMT5A or low CDH1 levels had the poorest prognosis with the shortest overall survival (OS) time, and this combination was demonstrated to be an independent prognostic indicator for patient OS time in ccRCC, more accurate than monitoring KMT5A or CDH1 alone. Together, these results indicate that KMT5A serves a vital role in ccRCC development and progression, and it may be a novel target for ccRCC treatment and prevention.Keywords
This publication has 31 references indexed in Scilit:
- A polymorphism at the miR‐502 binding site in the 3′‐untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcomeInternational Journal of Cancer, 2011
- SET8 promotes epithelial–mesenchymal transition and confers TWIST dual transcriptional activitiesThe EMBO Journal, 2011
- CRL4Cdt2-Mediated Destruction of the Histone Methyltransferase Set8 Prevents Premature Chromatin Compaction in S PhaseMolecular Cell, 2010
- CRL4Cdt2 Regulates Cell Proliferation and Histone Gene Expression by Targeting PR-Set7/Set8 for DegradationMolecular Cell, 2010
- Epidemiology and risk factors for kidney cancerNature Reviews Urology, 2010
- Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-CadherinMolecular Biology of the Cell, 2009
- Catalytic Function of the PR-Set7 Histone H4 Lysine 20 Monomethyltransferase Is Essential for Mitotic Entry and Genomic StabilityJournal of Biological Chemistry, 2008
- The histone methyltransferase SET8 is required for S-phase progressionJournal of Cell Biology, 2007
- Chromatin immunoprecipitation and microarray-based analysis of protein locationNature Protocols, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001